Back to search

Article

Processing body dynamics drive non-genetic MEK inhibitors tolerance by fine-tuning KRAS and NRAS translation

2021-12-07

Abstract excerpt

Overactivation of the Mitogen-activated protein kinase (MAPK) pathway is a critical driver of many human cancers. However, therapies targeting this pathway have proven effective in only a few cancers, as cancers inevitably develop resistance. Puzzling observations suggest that MAPK targeting fails in tumors due to early compensatory RAS overexpression, albeit by unexplained mechanisms. We identified a novel mechan...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ab69dc14-3ead-5559-9957-ceebfae2acde
DOI
10.1101/2021.12.06.471470
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Processing body dynamics drive non-genetic MEK inhibitors tolerance by fine-tuning KRAS and NRAS translationDOI 10.1101/2021.12.06.471470
Select a neighboring publication to make it the new centre.